Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Ultrastructural Features of Mast Cells in Human Omental Veins

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mast cells are relatively common in human omental veins where they generally occur in the tunica adventitia and among the peripheral smooth muscle cells of the tunica media. The distance between mast cells and adjacent muscle cells is often as short as 1 µm. The tunica intima does not contain mast cells. With few exceptions the typical mast cells were oval in shape, had numerous slender projections and contained granules (0.3–0.7 µm) with characteristic stacks of lamellae and scrolls. A few elongated cells with processes containing granules filled with dense homogeneous matrix material were also detected and could represent so-called chromaffin mast cells. Noradrenergic axons and terminals identified by their large (85 nm) and small (50 nm) dense-cored vesicles are present in the vicinity of many mast cells which could allow various interactions between the two cell types and their released amines and ATP. Electrical field stimulation which affects the nerve terminals does not change the ultrastructure of the mast cells unless the α-blocking agent phentolamine (7.5 × 10<sup>-7</sup> M) is present during the stimulation, when degranulation results.

          Related collections

          Author and article information

          Journal
          JVR
          J Vasc Res
          10.1159/issn.1018-1172
          Journal of Vascular Research
          S. Karger AG
          1018-1172
          1423-0135
          1979
          1979
          19 September 2008
          : 16
          : 6
          : 311-319
          Affiliations
          Departments of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Miss, and Department of Physiology, Karolinska Institute, Stockholm
          Article
          158221 Blood Vessels 1979;16:311–319
          10.1159/000158221
          © 1979 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 9
          Categories
          Original Paper

          Comments

          Comment on this article